Showing results (91-100 of 205) with videos related to

Sort By:
Pageof 21
Nature Reviews. Neurology|May 18, 2022
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utilityThomas K Karikari, Nicholas J Ashton, Gunnar Brinkmalm, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 12, 2025
Predicting survival rate by plasma biomarkers and clinical variables in syndromes associated with frontotemporal lobar degenerationMaria Sofia Cotelli, Barbara Tarantino, Kübra Tan, et al.
Brain Communications|May 14, 2026
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosisChristina N Heiss, Lenka Novakova, Markus Axelsson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 26, 2020
Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairmentTharick A Pascoal, Joseph Therriault, Sulantha Mathotaarachchi, et al.
Alzheimer'S Research & Therapy|June 6, 2022
Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer's diseaseJohanna Nilsson, Nicholas J Ashton, Andrea L Benedet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2026
[<sup>18</sup>F]RO948 Tau PET in early and late onset Alzheimer's disease: associations with plasma p-tau 217, atrophy and cognitionMariola Zapater-Fajari, Marco Bucci, Konstantinos Chiotis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2026
Analytical and clinical validation of the Lumipulse G plasma p-tau217 assay for clinical implementationBurak Arslan, Johan Gobom, Ulf Andreasson, et al.
Brain Communications|June 30, 2021
Interactive rather than independent effect of <i>APOE</i> and sex potentiates tau deposition in womenYi-Ting T Wang, Tharick A Pascoal, Joseph Therriault, et al.
Cannabis and Cannabinoid Research|November 17, 2022
Endocannabinoid System Biomarkers in Alzheimer's DiseasePâmela C L Ferreira, Bruna Bellaver, Guilherme Povala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2021
A multicenter comparison of [<sup>18</sup>F]flortaucipir, [<sup>18</sup>F]RO948, and [<sup>18</sup>F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosisAntoine Leuzy, Tharick A Pascoal, Olof Strandberg, et al.
Pageof 21